Aktis Oncology

Recent news

• Raymond James Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $40
  Market Newswire · 2026/6/16
• Rating change
  Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX)
  TipRanks · 2026/5/12
• J.P. Morgan Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $33
  Market Newswire · 2026/8/14
• Rating change
  Analysts Have Conflicting Sentiments on These NA Companies: Aktis Oncology, Inc. (AKTS), Bullish (BLSH) and SanDisk Corp (SNDK)
  TipRanks · 2026/8/14
• Rating change
  William Blair Maintains Aktis Oncology(AKTS.US) With Buy Rating
  Market Newswire · 2026/8/14
• Rating change
  TD Cowen Maintains Aktis Oncology(AKTS.US) With Buy Rating
  Market Newswire · 2026/5/12
• Rating change
  J.P. Morgan Maintains Aktis Oncology(AKTS.US) With Buy Rating, Raises Target Price to $33
  Market Newswire · 2026/7/14
• Rating change
  H.C. Wainwright Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $35
  Market Newswire · 2026/6/3
• Company notice
  Akoustis Technologies: Akoustis Technologies, Inc. - Symbol Change Option Symbol: AKTS New Symbol: AKTSQ
  OCC · 2024/12/18
• Rating change
  J.P. Morgan Keeps Their Buy Rating on Aktis Oncology, Inc. (AKTS)
  TipRanks · 2026/7/14
• Rating change
  H.C. Wainwright Maintains Aktis Oncology(AKTS.US) With Buy Rating, Raises Target Price to $35
  Market Newswire · 2026/6/3
• Rating change
  William Blair Initiates Aktis Oncology(AKTS.US) With Buy Rating, Announces Target Price $32
  Market Newswire · 2026/4/29
• Rating change
  Aktis Oncology, Inc. (AKTS) Receives a Buy From Bank of America Securities
  TipRanks · 2026/8/14
• Wedbush Initiates Aktis Oncology(AKTS.US) With Buy Rating, Announces Target Price $35
  Market Newswire · 2026/8/19
• Rating change
  William Blair Initiates Aktis Oncology(AKTS.US) With Buy Rating
  Market Newswire · 2026/5/6
• Oppenheimer Initiates Aktis Oncology(AKTS.US) With Buy Rating, Announces Target Price $40
  Market Newswire · 2026/9/9
• Wedbush Reaffirms Their Buy Rating on Aktis Oncology, Inc. (AKTS)
  TipRanks · 2026/10/5
• Rating change
  Analysts Are Bullish on Top NA Stocks: Aktis Oncology, Inc. (AKTS), Yesway Inc Class A (YSWY)
  TipRanks · 2026/8/14
• Rating change
  BofA Securities Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $34
  Market Newswire · 2026/8/14
• Rating change
  Bank of America Securities Remains a Buy on Aktis Oncology, Inc. (AKTS)
  TipRanks · 2026/6/1

Headlines are aggregated automatically and are not independently verified or edited by our team.